175
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Intensity of Catastrophic Health-care Expenditure for Type 2 Diabetes Mellitus Care in Iran: Determinants and Inequality

ORCID Icon, , ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 2865-2876 | Published online: 18 Aug 2020

References

  • Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002
  • Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants. Lancet. 2016;387(10027):1513–1530. doi:10.1016/S0140-6736(16)00618-8
  • Haghdoost A, Rezazadeh Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. EMHJ. 2009;15(3):591–599. doi:10.26719/2009.15.3.591
  • Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321. doi:10.1016/j.diabres.2011.10.029
  • Roglic G. WHO global report on diabetes: a summary. Int J Noncommun Dis. 2016;1(1):3. doi:10.4103/2468-8827.184853
  • WHO. Diabetes. World Health Organization; 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed May, 2020.
  • IRNA. The annual cost of diabetes in Iran is about $ 4 billion. The Islamic Republic news agency; 2018. Available from: www.irna.ir/news/83093821/. Accessed May, 2020.
  • Sun X, Liabsuetrakul T, Xie X, Liu P. Catastrophic health expenditure and impoverishment for type 2 diabetes mellitus patients in a multiethnic province in China using a Blinder–Oaxaca decomposition: a cross-sectional study. Medicine. 2019;98(39):e17376. doi:10.1097/MD.0000000000017376
  • Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185. doi:10.7150/ijms.10001
  • Lewis MT, Lujan HL, Tonson A, Wiseman RW, DiCarlo SE. Obesity and inactivity, not hyperglycemia, cause exercise intolerance in individuals with type 2 diabetes: solving the obesity and inactivity versus hyperglycemia causality dilemma. Med Hypotheses. 2019;123:110–114. doi:10.1016/j.mehy.2019.01.013
  • Jing Z, Chu J, Imam Syeda Z, et al. Catastrophic health expenditure among type 2 diabetes mellitus patients: a province‐wide study in Shandong, China. J Diabetes Investig. 2019;10(2):283–289. doi:10.1111/jdi.12901
  • Baudot F-O, Aguade A-S, Barnay T, Gastaldi-Menager C, Fagot-Campagna A. Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data. Eur J Health Econ. 2019;20(5):657–668. doi:10.1007/s10198-018-1024-9
  • Mapa-Tassou C, Katte J-C, Maadjhou CM, Mbanya JC. Economic impact of diabetes in Africa. Curr Diab Rep. 2019;19(2):5. doi:10.1007/s11892-019-1124-7
  • Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2020;162:108072. doi:10.1016/j.diabres.2020.108072
  • IDF. IDF Diabetes Atlas. 9th edition. International Diabetes Federation; 2019
  • Li H-F, Cai L, Golden AR. Short-term trends in economic burden and catastrophic costs of type 2 diabetes mellitus in rural Southwest China. J Diabetes Res. 2019;2019:1–6. doi:10.1155/2019/9626413
  • Rezaei S, Hajizadeh M, Ahmadi S, et al. Socioeconomic inequality in catastrophic healthcare expenditures in Western Iran. Int J Soc Econ. 2019;46(9):1049–1060. doi:10.1108/IJSE-01-2019-0034
  • Ahmadnezhad E, Murphy A, Alvandi R, Abdi Z. The impact of health reform in Iran on catastrophic health expenditures: equity and policy implications. Int J Health Plann Manage. 2019;34(4):e1833–e45. doi:10.1002/hpm.2900
  • Kavosi Z, Rashidian A, Pourreza A, et al. Inequality in household catastrophic health care expenditure in a low-income society of Iran. Health Policy Plan. 2012;27(7):613–623. doi:10.1093/heapol/czs001
  • Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;33(8):811–831. doi:10.1007/s40273-015-0268-9
  • Okoronkwo IL, Ekpemiro JN, Okwor EU, Okpala PU, Adeyemo FO. Economic burden and catastrophic cost among people living with type2 diabetes mellitus attending a tertiary health institution in south-east zone, Nigeria. BMC Res Notes. 2015;8(1):527. doi:10.1186/s13104-015-1489-x
  • Ghorbanian A, Rashidian A, Lankarani KB, Kavosi Z. The prevalence and determinants of catastrophic health expenditures in Iran: a systematic review and meta-analysis. Health Scope. 2019;8(1).
  • Esteghamati A, Etemad K, Koohpayehzadeh J, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–327. doi:10.1016/j.diabres.2013.12.034
  • Vahedi S, Rezapour A, Khiavi FF, et al. Decomposition of socioeconomic inequality in catastrophic health expenditure: an evidence from Iran. Clin Epidemiol Glob Health. 2019;8(2):437–441.
  • Rezaei S, Hajizadeh M. Measuring and decomposing socioeconomic inequality in catastrophic healthcare expenditures in Iran. J Prev Med Public Health. 2019;52(4):214. doi:10.3961/jpmph.19.046
  • Yazdi-Feyzabadi V, Bahrampour M, Rashidian A, Haghdoost A-A, Javar MA, Mehrolhassani MH. Prevalence and intensity of catastrophic health care expenditures in Iran from 2008 to 2015: a study on Iranian household income and expenditure survey. Int J Equity Health. 2018;17(1):44. doi:10.1186/s12939-018-0743-y
  • International Diabetes Federation. IDF MENA Members. Available from: https://idf.org/our-network/regions-members/middle-east-and-north-africa/members/35-iran.html. Accessed July 24, 2020.
  • Akbarzadeh A, Salehi A, Vardanjani HM, et al. Epidemiology of adult diabetes mellitus and its correlates in pars cohort study in Southern Iran. Arch Iran Med. 2019;22(11):633–639.
  • Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017;11:S347–S50. doi:10.1016/j.dsx.2017.03.014
  • O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Bull World Health Organ. 2008;86(10):816.
  • Moradi G, Moinafshar A, Adabi H, Sharafi M, Mostafavi F, Bolbanabad AM. Socioeconomic inequalities in the oral health of people aged 15–40 years in Kurdistan, Iran in 2015: a cross-sectional study. J Prev Med Public Health. 2017;50(5):303. doi:10.3961/jpmph.17.035
  • Xu K Distribution of health payments and catastrophic expenditures methodology. Distribution of health payments and catastrophic expenditures Methodology. 2005.
  • Wagstaff A, Doorslaer E. Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998. Health Econ. 2003;12(11):921–933. doi:10.1002/hec.776
  • Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362(9378):111–117. doi:10.1016/S0140-6736(03)13861-5
  • Gravelle H. Measuring income related inequality in health: standardisation and the partial concentration index. Health Econ. 2003;12(10):803–819. doi:10.1002/hec.813
  • Wagstaff A, Paci P, Van Doorslaer E. On the measurement of inequalities in health. Soc Sci Med. 1991;33(5):545–557. doi:10.1016/0277-9536(91)90212-U
  • Wagstaff A. The concentration index of a binary outcome revisited. Health Econ. 2011;20(10):1155–1160. doi:10.1002/hec.1752
  • Singh K, Narayan KMV, Eggleston K. Economic Impact of Diabetes in South Asia: the Magnitude of the Problem. Curr Diab Rep. 2019;19(6):34. doi:10.1007/s11892-019-1146-1
  • Piroozi B, Moradi G, Nouri B, Bolbanabad AM, Safari H. Catastrophic health expenditure after the implementation of health sector evolution plan: a case study in the west of Iran. Int J Health Policy Manage. 2016;5(7):417. doi:10.15171/ijhpm.2016.31
  • Adhikari SR, Maskay NM, Sharma BP. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences. Health Policy Plan. 2009;24(2):129–139. doi:10.1093/heapol/czn052
  • Su TT, Kouyaté B, Flessa S. Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ. 2006;84:21–27. doi:10.2471/BLT.05.023739
  • Group AS. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries. BMC Med. 2015;13(1):190.
  • Khan JA, Ahmed S, Evans TG. Catastrophic healthcare expenditure and poverty related to out-of-pocket payments for healthcare in Bangladesh—an estimation of financial risk protection of universal health coverage. Health Policy Plan. 2017;32(8):1102–1110. doi:10.1093/heapol/czx048
  • Amaya-Lara JL. Catastrophic expenditure due to out-of-pocket health payments and its determinants in Colombian households. Int J Equity Health. 2016;15(1):182. doi:10.1186/s12939-016-0472-z
  • Mutyambizi C, Pavlova M, Hongoro C, Booysen F, Groot W. Incidence, socio-economic inequalities and determinants of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals in Tshwane. Int J Equity Health. 2019;18(1):73. doi:10.1186/s12939-019-0977-3
  • Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care. 2012;35(2):319–326. doi:10.2337/dc11-1770